Non-medical Use (NMU) Data Report Services

SOL #: 75F40126R00013Solicitation

Overview

Buyer

Health And Human Services
Food And Drug Administration
FDA OFFICE OF ACQ GRANT SVCS
Rockville, MD, 20852, United States

Place of Performance

Silver Spring, MD

NAICS

Research and Development in the Social Sciences and Humanities (541720)

PSC

Health R&D Services; Health Care Other; Basic Research (AN41)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 18, 2026
2
Last Updated
Mar 16, 2026
3
Submission Deadline
Mar 19, 2026, 1:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Surveillance and Epidemiology (OSE) is soliciting proposals for Non-Medical Use (NMU) Data Report Services. This is a Multiple-Award Indefinite Delivery Indefinite Quantity (IDIQ) contract to obtain post-marketing surveillance data on the nonmedical use of prescription and over-the-counter drug products, illicit substances, and other emerging substances. Proposals are due by 9:00 AM Eastern on March 19, 2026.

Purpose & Scope

The primary objective is to inform FDA's pharmaceutical regulatory and oversight efforts, identify emerging substances of concern, and support NMU prevention programs. The surveillance scope includes FDA-approved prescription and OTC drugs, illicit substances, and emerging substances like psychedelics, tianeptine, xylazine, and cannabis. FDA prefers standardized self-reported data and single, large, established data systems, but will consider other approaches and integrated data systems. Offerors must provide and maintain access to a database of at least 50,000 subjects.

Key Requirements

  • Task Area 1: Post-Market Surveillance: Provide bi-annual summary reports, ad-hoc reports, and analytical datasets from existing surveillance data, including at least ten years of historical data.
  • Task Area 2: Topic-Specific Studies/Analyses: Conduct focused studies leveraging real-world data, subject-matter expertise, or literature reviews, potentially including internet panel surveys and qualitative analyses of internet postings.
  • Task Area 3: Project Management: Includes a kick-off meeting, Project Management Plan, Data Management Plan, Quality Assurance Surveillance Plan, and quarterly teleconferences.
  • Deliverables: Monthly, annual, and final project reports, submitted electronically and compliant with Section 508 accessibility standards.

Contract Details

  • Contract Type: Multiple-Award Indefinite Delivery Indefinite Quantity (IDIQ)
  • Period of Performance: Anticipated Base Year (Sept 30, 2026 - Sept 29, 2027) with four Option Years, totaling a 5-year IDIQ ordering period. Task orders may extend up to 36 months beyond the IDIQ expiration.
  • Estimated Value: Minimum guarantee of $3,000.00. Maximum aggregate value of all task orders is $8,500,000.00.
  • Set-Aside: UNRESTRICTED. Small business set-aside options (Small Business, HUBZone, WOSB, EDWOSB, SDVOSB, 8(A)) may be applied at the task order level.
  • NAICS Code: 541720 (Research and Development in the Social Sciences and Humanities).

Submission & Evaluation

  • Submission Deadline: Quotes are due by 9:00 AM Eastern on Thursday, March 19, 2026.
  • Questions Deadline: Questions were due by 9:00 AM Eastern on Thursday, March 5, 2026.
  • Submission Method: Electronically via email to Nam Nguyen (nam.nguyen@fda.hhs.gov).
  • Proposal Format: Proposals must be submitted in two separate volumes: Volume I-Technical and Volume II-Business/Price. The total page limit for both volumes combined is 50 pages, including covers, tables of contents, and appendices.
  • Evaluation Criteria: Best value trade-off process. Technical factors (Data Access and Capabilities, Technical Approach and Understanding, Personnel Qualifications, Quality Assurance and Data Management, Past Performance) are more important than Price. Confidence ratings will be used for technical factors.
  • Required Attachment: Offerors must complete and return "Attachment 1 - Pricing_Table.xlsx" with loaded labor hour prices for specified labor categories across five ordering periods.

Additional Notes

The FDA anticipates awarding a maximum of two IDIQ contracts. Active registration in SAM.gov is required.

People

Points of Contact

Nam NguyenPRIMARY

Files

Files

Download
Download

Versions

Version 4
Solicitation
Posted: Mar 16, 2026
View
Version 3
Solicitation
Posted: Mar 12, 2026
View
Version 2Viewing
Solicitation
Posted: Mar 11, 2026
Version 1
Solicitation
Posted: Feb 18, 2026
View
Non-medical Use (NMU) Data Report Services | GovScope